GB201210286D0 - Recombinant polypeptide - Google Patents

Recombinant polypeptide

Info

Publication number
GB201210286D0
GB201210286D0 GBGB1210286.9A GB201210286A GB201210286D0 GB 201210286 D0 GB201210286 D0 GB 201210286D0 GB 201210286 A GB201210286 A GB 201210286A GB 201210286 D0 GB201210286 D0 GB 201210286D0
Authority
GB
United Kingdom
Prior art keywords
recombinant polypeptide
polypeptide
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1210286.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Newcastle, The
Newcastle University of Upon Tyne
Original Assignee
University of Newcastle, The
Newcastle University of Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Newcastle, The, Newcastle University of Upon Tyne filed Critical University of Newcastle, The
Priority to GBGB1210286.9A priority Critical patent/GB201210286D0/en
Publication of GB201210286D0 publication Critical patent/GB201210286D0/en
Priority to EP13728816.3A priority patent/EP2858675A2/en
Priority to PCT/GB2013/051524 priority patent/WO2013186545A2/en
Priority to CN201380039320.1A priority patent/CN104703627A/en
Priority to JP2015516681A priority patent/JP6896216B2/en
Priority to US14/407,424 priority patent/US9862750B2/en
Ceased legal-status Critical Current

Links

GBGB1210286.9A 2012-06-11 2012-06-11 Recombinant polypeptide Ceased GB201210286D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1210286.9A GB201210286D0 (en) 2012-06-11 2012-06-11 Recombinant polypeptide
EP13728816.3A EP2858675A2 (en) 2012-06-11 2013-06-11 Recombinant polypeptide
PCT/GB2013/051524 WO2013186545A2 (en) 2012-06-11 2013-06-11 Recombinant polypeptide
CN201380039320.1A CN104703627A (en) 2012-06-11 2013-06-11 Chaperone/usher fusion proteins
JP2015516681A JP6896216B2 (en) 2012-06-11 2013-06-11 Recombinant polypeptide
US14/407,424 US9862750B2 (en) 2012-06-11 2013-06-11 Recombinant polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1210286.9A GB201210286D0 (en) 2012-06-11 2012-06-11 Recombinant polypeptide

Publications (1)

Publication Number Publication Date
GB201210286D0 true GB201210286D0 (en) 2012-07-25

Family

ID=46605741

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1210286.9A Ceased GB201210286D0 (en) 2012-06-11 2012-06-11 Recombinant polypeptide

Country Status (1)

Country Link
GB (1) GB201210286D0 (en)

Similar Documents

Publication Publication Date Title
HRP20190454T1 (en) Recombinant factor viii proteins
IL291571A (en) Cx3cr1-binding polypeptides
HK1217731A1 (en) Heterodimerized polypeptide
EP2857033A4 (en) Skin-permeating peptide
GB201220474D0 (en) Polypeptides
EP2812347A4 (en) Autophagy-inducing peptide
SG11201404180RA (en) Cho-gmt recombinant protein expression
HK1209138A1 (en) Peptides
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201204868D0 (en) Peptides
GB201200555D0 (en) Peptide
GB201223114D0 (en) Novel peptide
HK1201752A1 (en) Alternaria peptides
EP2891663A4 (en) Psf1-derived peptide
EP2805963A4 (en) Amyloid -protein-specific production-inhibiting polypeptide
HK1211952A1 (en) Recombinant protein
GB201210286D0 (en) Recombinant polypeptide
GB201300529D0 (en) Recombinant polypeptide
GB201204065D0 (en) Fusion polypeptide
GB201221414D0 (en) Trans-locating peptide
GB201220328D0 (en) Peptides
GB201211740D0 (en) Peptides
GB201207895D0 (en) Peptides
GB201200624D0 (en) Peptide
GB201200623D0 (en) Peptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)